Canopy Growth Corporation (NASDAQ:CGC – Get Free Report) has been assigned a consensus recommendation of “Hold” from the five research firms that are presently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company.
Several analysts have recently issued reports on the company. Wall Street Zen raised Canopy Growth from a “sell” rating to a “hold” rating in a report on Saturday, September 26th. Weiss Ratings raised shares of Canopy Growth from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, October 2nd.
Get Our Latest Stock Analysis on Canopy Growth
Institutional Trading of Canopy Growth
Canopy Growth Stock Down 1.6%
Shares of CGC stock opened at $0.88 on Thursday. The company has a current ratio of 3.04, a quick ratio of 2.39 and a debt-to-equity ratio of 0.31. Canopy Growth has a 12 month low of $0.84 and a 12 month high of $2.38. The stock has a market cap of $393.81 million, a P/E ratio of -1.95 and a beta of 0.78. The company has a 50 day simple moving average of $0.96 and a two-hundred day simple moving average of $1.00.
Canopy Growth (NASDAQ:CGC – Get Free Report) last announced its quarterly earnings data on Friday, August 7th. The company reported ($0.02) EPS for the quarter, beating the consensus estimate of ($0.04) by $0.02. Canopy Growth had a negative net margin of 65.33% and a negative return on equity of 21.91%. The firm had revenue of $142.62 million for the quarter, compared to the consensus estimate of $58.21 million. On average, research analysts expect that Canopy Growth will post -0.1 earnings per share for the current year.
Canopy Growth Company Profile
Canopy Growth Corporation is a cannabis company headquartered in Smiths Falls, Ontario. Founded in 2013 as Tweed Marijuana Inc, the company adopted the Canopy Growth name in 2015 and became one of Canada’s early large-scale licensed cannabis producers.
Canopy Growth develops, produces, distributes and sells cannabis products for the Canadian medical and adult-use markets. Its offerings include dried flower, pre-rolls, oils, softgels, vapes, beverages and edibles marketed under brands such as Tweed, 7ACRES, DOJA and Deep Space.
Featured Stories
- Five stocks we like better than Canopy Growth
- Skydance Just Became a Media Giant—With an $80 Billion Debt Load
- Could Velo3D Be the Next Defense Buyout Target?
- Penguin Solutions Is Soaring as AI Memory Demand Explodes
- Alphabet’s Chart Is Coiling—and the Fundamentals May Be Ready to Back It Up
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.
